Skip links and keyboard navigation

Health alert: Novel coronavirus (COVID-19)

Visitors are now able to attend our facilities in Metro South Health. Please refer to the visiting restrictions for more information.

Find out where to get tested at one of our fever clinic locations, where to get vaccinated, our COVID-19 response and read the latest Queensland Government information.

Cancer Collaborative Biobank (CCB)

The Cancer Collaborative Biobank (CCB) stores human biological biospecimens (samples) obtained with consent from patients diagnosed with a haematologic malignancy, for use in research. The CCB is housed at the Princess Alexandra Hospital, Brisbane.


The purpose of storing samples is to facilitate laboratory based research into haematologic malignancies.

The function of the CCB is to provide samples from patients with these diseases, for use in approved research projects – thereby facilitating a wide range of research activities.

The ultimate goal of facilitating such research is to improve our understanding of the processes leading to the development of haematologic malignancy, factors which govern the variable response to current treatments and ultimately the development of more effective therapies for patients suffering from haematologic malignancy.


The CCB operates within the Centres for Health Research and is overseen by the CCB Management Committee – made up of haematologists and interested professionals.  

The CCB operations have been reviewed and approved by the Metro South Health Human Research Ethics Committee.  All policies abide by the National Statement on the Ethical Conduct of Research Involving Humans from the NHMRC.


The CCB is funded by the Metro South Health Study, Education and Research Trust Account (SERTA) Committee until July 2018.

Last updated 3 April 2017
Last reviewed 3 April 2017